Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance

Marc A Dall'Era; Benjamin J Davies

doi:10.1016/j.euf.2015.07.001

Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active Surveillance

Eur Urol Focus. 2015 Sep;1(2):208-209. doi: 10.1016/j.euf.2015.07.001. Epub 2015 Jul 15.

Authors

Marc A Dall'Era¹, Benjamin J Davies²

Affiliations

¹ Department of Urology, University of California Davis, Davis Medical Center, Sacramento, CA, USA. Electronic address: [email protected].
² Department of Urology, University of Pittsburgh, Pittsburgh, PA, USA.

PMID: 28723436
DOI: 10.1016/j.euf.2015.07.001

Abstract

Active surveillance offers men the opportunity to defer immediate local treatment of low risk prostate cancer while preserving a highly functional quality of life. Novel biomarkers and imaging technology will enable physicians to better identify ideal candidates for this approach beyond traditional clinical characteristics.